Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Cuttsy+Cuttsy appoints Harriet Karia as Managing Director

January 4, 2024 | Agency news, Managing Director, healthcare agency 

Cuttsy+Cuttsy is pleased to announce the appointment of Harriet Karia as its first Managing Director.

Cambridge, UK — January 2024 — Cuttsy+Cuttsy, a healthcare communication agency, is pleased to announce the appointment of Harriet Karia as its first Managing Director. This move follows a period of substantial growth and is a practical step towards the agency’s future plans.

In her new role, Harriet will oversee Client Service and take on a broader agency overview, supported by the founders, Caroline Benson and Mathew Cutts.

Harriet joined Cuttsy+Cuttsy in early 2020 as an Account Director, quickly moving up to become Client Service Director. With over 20 years in the charity sector, including roles at Age UK (Help the Aged), Macmillan Cancer Support, and The Hospice of St Francis, Harriet has a wealth of experience in engaging the public and leading successful teams.

Caroline Benson, Co-Founder of Cuttsy+Cuttsy, said, “Harriet’s promotion is an exciting time for us, her natural leadership and strong relationships with clients and colleagues made her an obvious choice for the role. She will continue to ensure everyone gets the support they need, both inside and outside the agency.”

Mathew Cutts, Co-Founder, added, “With our recent growth, it’s time to set up the infrastructure to continue building a sustainable business that remains grounded in our values. Harriet is key to the prioritisation of our clients, our team, and the real impact our work has on people’s lives.”

Harriet commented, “I’m delighted to be taking on the role of Managing Director. Leading our talented team is a privilege, and I’m proud to work with individuals whose passion and creativity form the core of our success. I look forward to building on our achievements, nurturing our award-winning culture, and making a meaningful impact in healthcare communications.”

This content was provided by Cuttsy + Cuttsy

Company Details

Cuttsy and Cuttsy Logo

Cuttsy + Cuttsy

Email
Website

 Latest Content from  Cuttsy + Cuttsy 

Cuttsy+Cuttsy welcomes three new experts to the team

Cuttsy+Cuttsy is happy to be welcoming three new people to the team this month.

The gap between hype and reality, what patients really say about weight loss drugs

Explore real patient conversations about weight loss drugs, uncovering challenges, support strategies, and the critical need for clear, reliable healthcare communication.

Why patient-centricity depends on site-centricity in clinical trials

Explore why patient-centricity in clinical trials relies on site-centricity, emphasising the need to design trials that empower site teams to better support patients.

From cloudy to clear: visualising complex data privacy information

Discover how clear communication principles can transform complex clinical research topics, as we conclude our Health Literacy series with a practical example on participant data transparency.

UK clinical trial regs are changing — here’s what’s happening

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

The invisible influence on trial retention: why caregivers must be part of the plan

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and how to better support them.

Where it all began: why we wrote ‘The Site Factor’

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.

From text to context: Helping patients see side effects clearly

Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health Literacy series.

Why patient engagement must come first in rare disease trials

Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.

New Cuttsy+Cuttsy research shows why site support matters more than ever

Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...